Pricing Log in Create free account

Aclaris Therapeutics, Inc. (ACRS) vs Olema Pharmaceuticals, Inc. (OLMA)

Aclaris Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are both Biotechnology companies. Aclaris Therapeutics, Inc. and Olema Pharmaceuticals, Inc. are of similar size ($591.5M and $559.5M). Olema Pharmaceuticals, Inc. has the higher net margin (0.00% vs −1,244.1%) and the higher return on invested capital (0.00% vs −107.7%). Across the 13 metrics below, Olema Pharmaceuticals, Inc. leads on 7 and Aclaris Therapeutics, Inc. on 6.

Valuation

Metric ACRS OLMA Biotechnology median
P/E n/m n/m 10.60
P/S 90.59 n/m 9.40
P/B 3.48 1.77 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 74.41 n/m 9.02
Earnings yield (14.95%) (29.04%) (32.88%)
Free cash flow yield (12.99%) (21.63%) (23.13%)

Profitability

Metric ACRS OLMA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin (1,413.97%) 0.00% 0.00%
Net margin (1,244.09%) 0.00% 0.00%
Free cash flow margin (1,176.61%) 0.00% 0.00%
Return on equity (55.51%) (52.74%) (51.96%)
Return on assets (40.66%) (47.10%) (46.06%)
Return on invested capital (107.72%) 0.00% 0.00%

Growth

Metric ACRS OLMA Biotechnology median
Revenue growth (TTM) (59.34%) — 6.76%
EPS growth (last fiscal year) 69.01% 15.00% 29.88%
Revenue growth, 5-year CAGR 3.84% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRS OLMA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 5.09 8.86 4.97
Net debt to EBITDA 1.20 2.82 1.01

Dividend

Metric ACRS OLMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACRS OLMA Biotechnology median
Market cap 559.49m 591.48m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack